FDA Grants Priority Review to Genentech’s Gazyva for Adults With Primary Membranous Nephropathy
Go back to FDA Grants Priority Review to Genentech’s Gazyva for Adults With Primary Membranous Nephropathy| Roche Holding AG Basel American Depositary Shares (AMEX: RHHBY) | Delayed: 53.92 +2.22 (4.29%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $51.70 | 52 Week High | $35.13 | |||
| Open | $52.10 | 52 Week Low | $28.10 | |||
| Day High | $54.02 | P/E | N/A | |||
| Day Low | $51.99 | EPS | $0.00 | |||
| Volume | 3,376,899 | |||||
| Brown & Brown, Inc. (NYSE: RO) | Delayed: 8.49 +0.55 (6.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.94 | 52 Week High | $8.59 | |||
| Open | $7.94 | 52 Week Low | $7.82 | |||
| Day High | $8.59 | P/E | 6.53 | |||
| Day Low | $7.82 | EPS | $1.30 | |||
| Volume | 42,732 | |||||
| Roper Industries (NASDAQ: ROP) | Delayed: 355.12 +18.41 (5.47%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $336.71 | 52 Week High | $195.93 | |||
| Open | $365.74 | 52 Week Low | $155.79 | |||
| Day High | $369.15 | P/E | 66.13 | |||
| Day Low | $354.17 | EPS | $5.37 | |||
| Volume | 1,515,117 | |||||
